Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2007 · 190 citations · 29 references
MedicineBiostatisticsPathologyClinical EpidemiologyEpidemiologic MethodsEpidemiologyClinical Data InterpretationDisease PhenotypingInterindividual VariabilityBiological VariationDisease-state Related VariabilityInter-subject VariabilityReference Value SelectionReference Value ValidationSubject Variability AssessmentWithin-patient Variability
Quantitative data on biological variation are used to calculate reference change values for serial results, and pathology can alter both the set point and the variation around it. The study collates all published within‑subject biological variation data for disease states other than health. The authors report within‑subject coefficients of variation for 66 quantities in 34 diseases, compare them to healthy values, and evaluate their clinical usefulness. Most quantities exhibit similar variation in disease and health, so healthy‑derived reference change values are generally adequate, but for a few disease‑specific markers the variation differs, indicating that disease‑specific reference change values may be clinically useful.
Quantitative data on the components of biological variation (BV) are used for several purposes, including calculating the reference change value (RCV) required for the assessment of the significance of changes in serial results in an individual. Pathology may modify the set point in diseased patients and, more importantly, the variation around that set-point. Our aim was to collate all published BV data in situations other than health. We report the within-subject coefficient of variation (CV(I)) for 66 quantities in 34 disease states. We compared the results with the CV(I) determined in healthy individuals and examined whether the data derived in specific diseases could be useful for clinical applications. For the majority of quantities studied, CV(I) values are of the same order in disease and health: thus the use of RCV derived from healthy subjects for monitoring patients would be reasonable. However, for a small number of quantities considered to be disease specific markers, the CV(I) differed from those in health. This could mean that RCV derived from healthy CV(I) may be inappropriate for monitoring patients in certain diseases. Hence, disease-specific RCVs may be clinically useful.
29
Sanne Bruins, M. Rebecca Fokkema, Jeroen W.P. Römer et al. · Clinical Chemistry · 2004 · 221 citations · Full text
Carmen Ricós, Fernando Cava, José Vicene Garcı́a-Lario et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 2004 · 167 citations